相关实验视频

Updated: May 20, 2025

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

针对HER2增强结直肠癌的向治疗方法的进展和挑战

Margot Pizzamiglio¹, Audrey Soulabaille¹, Widad Lahlou¹

¹Université Paris Cité, Assistance Publique - Hôpitaux de Paris, Department of Digestive Oncology, Hôpital européen Georges Pompidou, Paris, France.

European journal of cancer (Oxford, England : 1990)

|May 1, 2025

概括

人类表皮生长因子受体2 (HER2) 是转移性结直肠癌 (CRC) 的可药用生物标志物. 针对性疗法对HER2阳性CRC患者有希望,最近FDA批准了特定治疗方法.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

结肠直肠癌 (CRC) 是欧洲癌症死亡的主要原因.
尽管标准疗法的进展,转移性CRC的预后仍然很差.
精准医学正在通过生物标志物驱动疗法彻底改变CRC治疗.

研究的目的:

审查HER2在结直肠癌中的预后和预测价值.
探索HER2作为转移性CRC的治疗点的作用.
讨论针对HER2向治疗的诊断方法和临床试验.

主要方法:

对HER2在CRC中的预后和预测价值的文献综述.
对HER2-改变的CRC分子结构和临床特征的分析.
对针对HER2的治疗方案的诊断方法和临床试验数据的检查.

主要成果:

在RAS野生型转移性CRC中,HER2放大/过度表达发生在~6%.
抗HER2疗法在HER2阳性转移性CRC中显示出有希望的结果.
美国食品和药物管理局最近批准了图卡替尼和特拉斯图祖马布-德鲁克斯坦在先前治疗的HER2阳性转移性CRC中.

结论:

在转移性结直肠癌中,HER2 是一种重要的,可用药物的生物标志物.
针对性抗HER2疗法正在成为特定CRC亚组治疗指南的组成部分.
进一步的研究和临床试验对于确定HER2在CRC中的全部治疗潜力至关重要.

关键词:

对抗HER2的治疗方法.结肠直肠癌是一种癌症.在HER2受体中,HER2受体是精准医学是一门精准的医学.有针对性的治疗方法.

更多相关视频

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.